Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
USAP | -18.90% | $419.25M | +147.80% | 0.00% |
DMLP | -15.57% | $1.59B | +3.19% | 10.35% |
NNVC | -14.74% | $17.22M | +15.38% | 0.00% |
TPST | -14.30% | $39.07M | -77.68% | 0.00% |
LEU | -13.90% | $1.21B | +34.68% | 0.00% |
FLNG | -13.40% | $1.39B | -13.12% | 12.02% |
CCJ | -12.94% | $21.55B | +3.56% | 0.23% |
PAYS | -12.23% | $159.57M | +16.41% | 0.00% |
LPG | -11.94% | $1.09B | -31.19% | 0.00% |
NAT | -11.44% | $584.63M | -37.08% | 14.44% |
FRO | -11.43% | $3.89B | -20.86% | 11.38% |
DHT | -11.27% | $1.76B | -1.00% | 9.39% |
SVM | -11.10% | $665.74M | +31.90% | 0.83% |
BSM | -10.92% | $3.27B | -3.90% | 10.33% |
STNG | -10.87% | $2.89B | -17.07% | 3.06% |
CRIS | -10.42% | $26.92M | -74.02% | 0.00% |
MVO | -9.84% | $93.84M | -29.04% | 16.05% |
RILY | -9.53% | $146.09M | -77.67% | 20.49% |
NOAH | -9.41% | $703.52M | -2.13% | 9.97% |
TNK | -9.25% | $1.53B | -19.77% | 2.33% |
Current Value
$60.311 Year Return
Current Value
$60.311 Year Return
Finnhub
WATERTOWN, Mass., Jan. 17, 2025 -- Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients...
Yahoo
In Q1 2025, the Company will discuss the plans for NDA submission under a potential accelerated approval path for bitopertin in erythropoietic protoporphyria (EPP), following a Type C meeting with FDA on confirmatory study designInitial data from an ongoing phase 2 study of DISC-0974 (anti-hemojuvelin antibody) in anemia of myelofibrosis (MF) expected H2 2025 Data from higher doses and multiple dose cohorts of a phase 1b study of DISC-0974 in anemia of chronic kidney disease (CKD) expected H2 20
Yahoo
Key Insights Using the 2 Stage Free Cash Flow to Equity, Disc Medicine fair value estimate is US$89.52 Disc Medicine's...
Yahoo
Positive updates across all programs, including updates from ongoing clinical studies and new translational data in preclinical models supporting use in existing and additional indicationsManagement hosted a conference call during the ASH meeting on Sunday, December 8 discussing highlights of the presented data and next steps for the company WATERTOWN, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,
Yahoo
Demonstrated durable hematologic response across all patient subgroups, regardless of baseline transfusion status and concomitant JAK inhibitor therapyPhase 2 study in MF anemia has been initiated, enrolling a broad range of patient types WATERTOWN, Mass., Dec. 08, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic di
Finnhub
Disc Medicine, Inc. presented positive updated results from a Phase 1b trial of DISC-0974 in patients with myelofibrosis and anemia. The data, presented in an oral session at the 2024 American Society...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BABA | <0.01% | $197.37B | +22.16% | 1.20% |
WTTR | -0.02% | $1.47B | +99.16% | 1.76% |
HEES | 0.02% | $3.25B | +84.21% | 1.24% |
UUUU | -0.04% | $996.78M | -33.29% | 0.00% |
SFL | 0.07% | $1.58B | -10.04% | 9.93% |
SILV | -0.08% | $1.47B | +67.74% | 0.00% |
CAPR | 0.08% | $613.84M | +226.88% | 0.00% |
ZTO | -0.08% | $11.25B | +5.97% | 5.07% |
RDDT | -0.09% | $30.70B | +414.32% | 0.00% |
ACGL | -0.09% | $36.16B | +27.99% | 0.00% |
ASML | 0.09% | $290.86B | +0.77% | 0.87% |
FATBB | 0.11% | $80.77M | -20.10% | 11.55% |
NERV | -0.11% | $15.04M | -69.33% | 0.00% |
HIMX | 0.11% | $1.53B | +48.90% | 3.31% |
IDT | 0.11% | $1.20B | +41.25% | 0.42% |
LFVN | 0.12% | $316.89M | +341.54% | 0.62% |
SHAK | 0.13% | $4.68B | +71.09% | 0.00% |
GIS | -0.13% | $32.61B | -6.56% | 4.04% |
BWA | 0.13% | $7.00B | -2.26% | 1.37% |
SSSS | -0.14% | - | - | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TEM | 37.76% | $5.47B | 0.00% | 0.00% |
KALV | 34.14% | $407.70M | -33.79% | 0.00% |
ZYME | 32.82% | $971.58M | +41.89% | 0.00% |
GSAT | 32.27% | $3.52B | +5.08% | 0.00% |
CWCO | 30.70% | $418.52M | -19.40% | 1.54% |
IDYA | 29.06% | $1.96B | -45.25% | 0.00% |
NGNE | 28.69% | $369.87M | -41.60% | 0.00% |
ATXS | 28.40% | $437.37M | +9.00% | 0.00% |
IART | 28.32% | $1.79B | -45.18% | 0.00% |
IDCC | 27.05% | $4.35B | +63.85% | 0.98% |
URGN | 26.86% | $443.94M | -26.28% | 0.00% |
CUZ | 26.73% | $5.05B | +31.50% | 4.21% |
KOD | 26.66% | $402.05M | +148.86% | 0.00% |
UWMC | 26.01% | $975.91M | -0.32% | 6.39% |
ODD | 25.83% | $2.49B | +2.84% | 0.00% |
ACLX | 25.42% | $3.62B | +26.01% | 0.00% |
SAFE | 25.36% | $1.22B | -12.40% | 4.08% |
JBGS | 25.15% | $1.30B | -5.22% | 5.61% |
HIW | 24.99% | $3.16B | +36.62% | 6.67% |
NTLA | 24.84% | $959.42M | -62.68% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -14.81% | $195.31M | 0.85% |
CTA | -13.84% | $553.08M | 0.76% |
CANE | -11.04% | $11.58M | 0.29% |
DBA | -10.89% | $817.28M | 0.93% |
URNM | -10.53% | $1.49B | 0.75% |
USCI | -9.60% | $201.05M | 1.07% |
TPMN | -9.39% | $41.98M | 0.65% |
URNJ | -8.42% | $257.40M | 0.8% |
USDU | -7.70% | $396.64M | 0.5% |
UNG | -7.35% | $852.04M | 1.06% |
KCCA | -7.06% | $105.80M | 0.87% |
URA | -7.05% | $3.36B | 0.69% |
CORN | -6.44% | $65.53M | 0.2% |
UUP | -6.14% | $636.64M | 0.77% |
KRBN | -5.71% | $198.93M | 0.85% |
FTGC | -5.58% | $2.32B | 1.02% |
WEAT | -4.37% | $121.95M | 0.28% |
PDBC | -4.01% | $4.40B | 0.59% |
BCD | -3.79% | $242.75M | 0.3% |
KMLM | -3.77% | $330.04M | 0.9% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPER | 0.01% | $155.20M | 0.97% |
FXI | -0.01% | $6.88B | 0.74% |
GXC | -0.13% | $388.10M | 0.59% |
MCHI | 0.18% | $4.92B | 0.6% |
SIL | 0.29% | $1.11B | 0.65% |
XLE | 0.29% | $35.04B | 0.09% |
PXJ | -0.36% | $40.24M | 0.66% |
FENY | 0.46% | $1.59B | 0.084% |
DBE | -0.49% | $50.40M | 0.77% |
IEO | 0.50% | $621.50M | 0.4% |
MINT | 0.52% | $12.10B | 0.35% |
VDE | 0.53% | $8.04B | 0.1% |
FTXN | 0.53% | $168.31M | 0.6% |
SOYB | -0.56% | $25.86M | 0.22% |
GCC | -0.65% | $134.16M | 0.55% |
EWH | 0.70% | $596.35M | 0.5% |
RSPG | 0.75% | $555.79M | 0.4% |
PXE | 0.75% | $108.61M | 0.63% |
SILJ | 0.87% | $888.28M | 0.69% |
KLIP | -0.98% | $120.94M | 0.93% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GBIL | 47.31% | $5.81B | 0.12% |
RSPA | 31.77% | $270.72M | 0% |
XBI | 30.14% | $5.97B | 0.35% |
GHYB | 30.07% | $143.49M | 0.34% |
PTH | 28.99% | $116.47M | 0.6% |
EFAA | 26.88% | $102.96M | 0% |
IBB | 26.59% | $6.29B | 0.45% |
XHE | 26.59% | $214.32M | 0.35% |
PINK | 26.06% | $140.10M | 0.5% |
ARKG | 25.94% | $1.12B | 0.75% |
GNOM | 24.89% | $67.37M | 0.5% |
XMPT | 24.87% | $197.13M | 1.98% |
PHB | 24.42% | $382.79M | 0.5% |
ANGL | 24.33% | $2.99B | 0.25% |
BGRN | 24.19% | $392.67M | 0.2% |
PCEF | 24.14% | $811.31M | 3.08% |
BSJP | 24.01% | $1.01B | 0.42% |
HYDB | 23.94% | $1.19B | 0.35% |
WCLD | 23.63% | $459.62M | 0.45% |
RWR | 23.62% | $1.79B | 0.25% |